Opportunities for investors

The NHSIL Xpedite^® pre-commercialization and business creation process provides a continuous deal flow in medical devices, medical diagnostics, pharmaceuticals, healthcare software and services.

Our investment opportunities are at an advanced level of early stage 'de-risking' as a result of the objective, highly analytical and rigorous Xpedite^® pre-commercialization feasibility, validation and virtual product development proof of concept process undertaken by NHSIL.

To find out more about our investment opportunities please contact David Chilvers, Chief Executive directly.

Also, check out Xpedite^® Ventures Ltd for opportunities to invest in managed funds including the Xpedite^® Healthcare Innovations Seed Fund.